Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803075 · ClinicalTrials.gov registry record · Phase 4
Endovascular Repair of Abdominal Aortic Aneurysms
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 142
- Enrollment target
NCT00803075: Completed Phase 4 study, sponsored by Stanford University.
NCT00803075 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 142 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00803075, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 142 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if it is safe and effective to use the TALENT AAA Stent Graft System as a treatment for AAAs in patients who are also candidates for conventional surgical aneurysm repair.
Interventions
- DEVICE Endovascular Repair of Abdominal Aortic Aneurysms Using TALENT AAA Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2002-02 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
What the finished NCT00803075 record still lists
NCT00803075 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which Endovascular Repair of Abdominal Aortic Aneurysms Using TALENT AAA Stent Graft System is the first listed.
NCT00803075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00803075 about?
NCT00803075 is a clinical study titled "Endovascular Repair of Abdominal Aortic Aneurysms". The purpose of this study is to determine if it is safe and effective to use the TALENT AAA Stent Graft System as a treatment for AAAs in patients who are also candidates for conventional surgical aneurysm repair.
What is the current status of trial NCT00803075?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 142 participants. The study started on 2002-02. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00803075?
The interventions under investigation include: Endovascular Repair of Abdominal Aortic Aneurysms Using TALENT AAA Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT00803075?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00803075's enrollment target sits among peer trials
142 580th of 2000 higher than 1,421 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia